HC Wainwright & Co. Maintains Buy on Asensus Surgical, Lowers Price Target to $2
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Asensus Surgical (AMEX:ASXC) with a Buy and lowers the price target from $3 to $2.
Earnings Scheduled For March 2, 2023
Companies Reporting Before The Bell
• argenx (NASDAQ:ARGX) is expected to report quarterly loss at $3.03 per share on revenue of $176.89 million.
HC Wainwright & Co. Reiterates Buy on Asensus Surgical, Maintains $3 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Buy and maintains $3 price target.
Asensus Surgical Provides Corporate Update In Conjunction With Its Previously Announced Investor Day, Which Will Be Hosted Today, Beginning At 11:30am ET
Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, is providing this corporate
HC Wainwright & Co. Reiterates Buy on Asensus Surgical, Maintains $3 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Buy and maintains $3 price target.
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 329 companies set new 52-week lows.
Asensus Announces A Senhance Surgical System Has Been Sold To The Company’s Distribution Partner In Germany
Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that a
Cantor Fitzgerald Initiates Coverage On This ‘Attractively Valued’ MedTech Stock
Cantor Fitzgerald initiated coverage on Asensus Surgical Inc (NYSE:ASXC) with an Overweight rating and a price target of $1.50. ASXC is a…
